Compatible with most pressurization systems! Provides rapid pressurized filtration for medium-capacity aqueous solutions at laboratory level.
The "AcroCap Pressure Filtration Device" provides rapid pressure filtration for medium-capacity aqueous solutions at the laboratory level. It prevents air locks with a complete hydrophobic air vent mechanism. The inlet can be connected to a 6.4 mm tube or various male luer slips, making it compatible with most pressure systems. 【Features】 ■ Prevents air locks with a complete hydrophobic air vent mechanism ■ Removes mycoplasma (0.1 μm pore size) ■ Compatible with most pressure systems ■ The inlet can be connected to a 6.4 mm tube or various male luer slips *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Partial)】 ■ Maximum operating pressure: 210 kPa ■ Standard flow rate (water) ・ Differential pressure: at 100 kPa, 0.1 μm: 90 mL/min 0.2 μm: 220 mL/min 0.45 μm: 500 mL/min ■ Endotoxin level: below 0.25 EU/mL as per Limulus test (LAL) * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Suitable for the clarification filtration of cell (tissue) culture media and media additives without serum, as well as other aqueous solutions up to 3L. ■ Suitable for solutions that foam during suction filtration. *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.